Insight Pharma Reports Announces Disease-Related Biomarkers Market Study

NEEDHAM, Mass. - Aug. 20, 2014 - PRLog -- Insight Pharma Reports, a scientific report leader for over 15 years, released a new market study on Disease-Related Biomarkers. This Market Study was conducted to further understand the applications of biomarkers in the research community. Completed with an in-depth analysis, this survey provides a snapshot of the growth of biomarkers in R&D and their significance in therapeutic development. Included are 12 questions that breakdown the demographics of this space, highlighting the main industries involved in biomarker identification, the specific properties under investigation, therapeutic targets, clinical statuses, and a retrospective market outlook.

For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com/BMK-survey-2014 or contact Kerri Kelley at kkelley@healthtech.com or 781-972-1347.


About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/